|
|
ATTR-CM is an underdiagnosed and often misdiagnosed cause of heart failure. In the United States, the hereditary form of ATTR, in particular the Val142Ile variant, is more prevalent in the African…
|
|
|
Dr. Steven Nissen, Chief Academic Officer, Chief Academic Officer, Sydell and Arnold Miller Family Heart & Vascular Institute talks about cardiomyopathy with Wilson Tang, MD, Director of…
|
|
|
Mazen Hanna, MD, Co-Director of the Cleveland Clinic’s Amyloidosis Center talks about the FDA’s recent approval of the drug Tafamidis for the treatment of ATTR Amyloidosis (also known as…
|
|
|
Dr. Mazen Hanna describes the findings of ATTR-ACT, a study aimed at the treatment of transthyretin (TTR) amyloid cardiomyopathy with the medication tafamadis. Those who were treated with the…
|
|
|
Cardiac Amyloidosis Dr. Mazen Hanna, co-director of Cleveland Clinic’s Amyloidosis Center leads this deep dive view of cardiac amyloidosis. Following a case study, experts provide insight into…
|